Cargando…

Engineering of Biocompatible Coacervate-Based Synthetic Cells

[Image: see text] Polymer-stabilized complex coacervate microdroplets have emerged as a robust platform for synthetic cell research. Their unique core–shell properties enable the sequestration of high concentrations of biologically relevant macromolecules and their subsequent release through the sem...

Descripción completa

Detalles Bibliográficos
Autores principales: van Stevendaal, Marleen H. M. E., Vasiukas, Laurynas, Yewdall, N. Amy, Mason, Alexander F., van Hest, Jan C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908014/
https://www.ncbi.nlm.nih.gov/pubmed/33587612
http://dx.doi.org/10.1021/acsami.0c19052
_version_ 1783655616091258880
author van Stevendaal, Marleen H. M. E.
Vasiukas, Laurynas
Yewdall, N. Amy
Mason, Alexander F.
van Hest, Jan C. M.
author_facet van Stevendaal, Marleen H. M. E.
Vasiukas, Laurynas
Yewdall, N. Amy
Mason, Alexander F.
van Hest, Jan C. M.
author_sort van Stevendaal, Marleen H. M. E.
collection PubMed
description [Image: see text] Polymer-stabilized complex coacervate microdroplets have emerged as a robust platform for synthetic cell research. Their unique core–shell properties enable the sequestration of high concentrations of biologically relevant macromolecules and their subsequent release through the semipermeable membrane. These unique properties render the synthetic cell platform highly suitable for a range of biomedical applications, as long as its biocompatibility upon interaction with biological cells is ensured. The purpose of this study is to investigate how the structure and formulation of these coacervate-based synthetic cells impact the viability of several different cell lines. Through careful examination of the individual synthetic cell components, it became evident that the presence of free polycation and membrane-forming polymer had to be prevented to ensure cell viability. After closely examining the structure–toxicity relationship, a set of conditions could be found whereby no detrimental effects were observed, when the artificial cells were cocultured with RAW264.7 cells. This opens up a range of possibilities to use this modular system for biomedical applications and creates design rules for the next generation of coacervate-based, biomedically relevant particles.
format Online
Article
Text
id pubmed-7908014
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-79080142021-02-26 Engineering of Biocompatible Coacervate-Based Synthetic Cells van Stevendaal, Marleen H. M. E. Vasiukas, Laurynas Yewdall, N. Amy Mason, Alexander F. van Hest, Jan C. M. ACS Appl Mater Interfaces [Image: see text] Polymer-stabilized complex coacervate microdroplets have emerged as a robust platform for synthetic cell research. Their unique core–shell properties enable the sequestration of high concentrations of biologically relevant macromolecules and their subsequent release through the semipermeable membrane. These unique properties render the synthetic cell platform highly suitable for a range of biomedical applications, as long as its biocompatibility upon interaction with biological cells is ensured. The purpose of this study is to investigate how the structure and formulation of these coacervate-based synthetic cells impact the viability of several different cell lines. Through careful examination of the individual synthetic cell components, it became evident that the presence of free polycation and membrane-forming polymer had to be prevented to ensure cell viability. After closely examining the structure–toxicity relationship, a set of conditions could be found whereby no detrimental effects were observed, when the artificial cells were cocultured with RAW264.7 cells. This opens up a range of possibilities to use this modular system for biomedical applications and creates design rules for the next generation of coacervate-based, biomedically relevant particles. American Chemical Society 2021-02-15 2021-02-24 /pmc/articles/PMC7908014/ /pubmed/33587612 http://dx.doi.org/10.1021/acsami.0c19052 Text en © 2021 The Authors. Published by American Chemical Society Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle van Stevendaal, Marleen H. M. E.
Vasiukas, Laurynas
Yewdall, N. Amy
Mason, Alexander F.
van Hest, Jan C. M.
Engineering of Biocompatible Coacervate-Based Synthetic Cells
title Engineering of Biocompatible Coacervate-Based Synthetic Cells
title_full Engineering of Biocompatible Coacervate-Based Synthetic Cells
title_fullStr Engineering of Biocompatible Coacervate-Based Synthetic Cells
title_full_unstemmed Engineering of Biocompatible Coacervate-Based Synthetic Cells
title_short Engineering of Biocompatible Coacervate-Based Synthetic Cells
title_sort engineering of biocompatible coacervate-based synthetic cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908014/
https://www.ncbi.nlm.nih.gov/pubmed/33587612
http://dx.doi.org/10.1021/acsami.0c19052
work_keys_str_mv AT vanstevendaalmarleenhme engineeringofbiocompatiblecoacervatebasedsyntheticcells
AT vasiukaslaurynas engineeringofbiocompatiblecoacervatebasedsyntheticcells
AT yewdallnamy engineeringofbiocompatiblecoacervatebasedsyntheticcells
AT masonalexanderf engineeringofbiocompatiblecoacervatebasedsyntheticcells
AT vanhestjancm engineeringofbiocompatiblecoacervatebasedsyntheticcells